Tools · Private company
Delfi Diagnostics Inc.
Track this companyFree. Adds Delfi Diagnostics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Ability to order FirstLook™Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Blood Sample CollectionLung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Continuing Medical Education for Lung CancerLung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung CancerNA · COMPLETED · started Oct 31, 2023ClinicalTrials.gov NCT06145750 · fetched Nov 12, 2026
- CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in LungACTIVE_NOT_RECRUITING · started Apr 7, 2022ClinicalTrials.gov NCT05306288 · fetched Nov 12, 2026
- DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)COMPLETED · started Mar 22, 2021ClinicalTrials.gov NCT04825834 · fetched Nov 12, 2026